Literature DB >> 16262878

The causative pathogens of onychomycosis in southern Taiwan.

Ching-Chi Chi1, Shu-Hui Wang, Ming-Chih Chou.   

Abstract

Selecting an appropriate antimycotic targeting the pathogens are among the most important factors for successfully treating onychomycosis. The aim of this study was to investigate the pathogens of onychomycosis in southern Taiwan and analyse the association between various factors and the distribution of pathogens. A total of 375 patients with onychomycosis were enrolled. Histopathological examination and fungus culture of nail specimens were performed. The pathogens were dermatophytes in 227 patients (60.5%), Candida in 118 (31.5%) and moulds in 30 (8%). Compared to patients with toenail involvement, the odds ratio (OR) for those with fingernail involvement to have non-dermatophytic onychomycosis (NDO), i.e. onychomycosis caused by Candida and moulds, was 5.04 [95% confidence interval (CI): 2.21-11.15], and the OR for those with fingernail and toenail involvement to have NDO was 2.66 (95% CI: 1.61-4.34). The F/M OR to have NDO was 2.36 (95% CI: 1.51-3.61), and 9.80 for diabetics (95% CI: 1.01-106.85). The OR for patients with paronychia to have NDO was 10.33 (95% CI: 5.61-18.88) compared to those without paronychia. Compared to patients with a non-wet occupation, the OR for those with a wet occupation to have NDO was 4.76 (95% CI: 2.01-11.16). The distribution of pathogens significantly varies with the involved sites, patients' gender and occupation, and presence of diabetes mellitus or paronychia. In contrast to temperate western countries, NDO is more prevalent in the tropics and subtropics including southern Taiwan.

Entities:  

Mesh:

Year:  2005        PMID: 16262878     DOI: 10.1111/j.1439-0507.2005.01152.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  8 in total

1.  [Health effects of indoor molds].

Authors:  Walter Buzina
Journal:  Wien Med Wochenschr       Date:  2007

2.  Emergence of fusarioses in a university hospital in Turkey during a 20-year period.

Authors:  B Dalyan Cilo; A M S Al-Hatmi; S Seyedmousavi; A J M M Rijs; P E Verweij; B Ener; G S de Hoog; A D van Diepeningen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-21       Impact factor: 3.267

3.  A study on the etiological agent and clinico-mycological correlation of fingernail onychomycosis in eastern India.

Authors:  Nilay Kanti Das; Pramit Ghosh; Suchibrata Das; Susmita Bhattacharya; Rathindra Nath Dutta; Sujit Ranjan Sengupta
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 4.  Candidal onychomycosis: a mini-review.

Authors:  J A M S Jayatilake; W M Tilakaratne; G J Panagoda
Journal:  Mycopathologia       Date:  2009-05-31       Impact factor: 2.574

5.  Tazarotene as alternative topical treatment for onychomycosis.

Authors:  Elena Campione; Evelin Jasmine Paternò; Gaetana Costanza; Laura Diluvio; Isabella Carboni; Daniele Marino; Cartesio Favalli; Sergio Chimenti; Luca Bianchi; Augusto Orlandi
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

6.  Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts.

Authors:  Mahnaz Fatahinia; Sima Jafarpour; Abdollah Rafiei; Simin Taghipour; Koichi Makimura; Ali Rezaei-Matehkolaei
Journal:  Curr Med Mycol       Date:  2017-12

7.  Application of polymerase chain reaction (PCR) and PCR based restriction fragment length polymorphism for detection and identification of dermatophytes from dermatological specimens.

Authors:  R Bagyalakshmi; B Senthilvelan; K L Therese; S Murugusundram; H N Madhavan
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

8.  A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination In Vitro Susceptibilities of Isolated Fungal Strains to Conventional and New Antifungals.

Authors:  Samaneh Halvaee; Roshanak Daie-Ghazvini; Seyed Jamal Hashemi; Sadegh Khodavaisy; Abbas Rahimi-Foroushani; Heidar Bakhshi; Zahra Rafat; Pegah Ardi; Mahdi Abastabar; Mahdi Zareei; Zeinab Borjian-Boroujeni; Hasti Kamali Sarvestani
Journal:  Front Cell Infect Microbiol       Date:  2021-07-15       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.